Changes in tear volume and ocular symptoms of patients receiving oral anticancer drug S-1

• Hoofdauteurs: Reiko Kuriki (Auteur), Tsuyoshi Hata (Auteur), Kinuyo Nakayama (Auteur), Yuichi Ito (Auteur), Kazunari Misawa (Auteur), Seiji Ito (Auteur), Michiko Tatematsu (Auteur), Norio Kaneda (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2018-02-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background Most eye disorders are not fatal but may deteriorate the quality of life of a patient. The eye disorder that is most frequently reported in the cancer chemotherapy is associated with the combination of tegafur/gimeracil/potassium oxonate (S-1). However, preventive methods or trea...